Spinal Modulation raises $27M to treat spinal pain
Spinal Modulation, a company that makes treatments for chronic spinal pain, has brought in $27.4 million in a third round of capital to finance trials of its lead medical device. Based in Menlo Park, Calif., the company is backed by Johnson & Johnson Development Corp., InCube Ventures, Raffle Venture Partners, DeNovo Ventures, DFJ ePlanet Ventures, Kleiner Perkins Caufield & Byers and MedVenture Associates.
Next Story: Verayo uses unique flaws in chips to fight counterfeiting
Previous Story: Cambrios lands $14.5M for electronic display components
About the Author, Camille Ricketts
Camille was the lead writer for GreenBeat until August 2010. To reach VentureBeat's current writers, email tips@venturebeat.com.
